Venezuela is the first Latin American country to participate in late-stage clinical trials of Russia’s COVID-19 vaccine candidate, the Sputnik-V. And Venezuelans are among the 40,000 people involved worldwide.
The widespread human testing is a key factor for the vaccine’s approval.
The Venezuelan government, which received 2,000 doses of Sputnik-V in early October, is giving its full support to the clinical trial.
“My son and my oldest sister will participate at this stage, and as soon as we start the massive vaccination, I will be the first to get it too,” said Nicolás Maduro, President of Venezuela.
But even if the vaccine is approved, not everyone is enthusiastic about getting the shot.
Mary Triny Mena reports from Caracas.